We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you accept our Privacy Policy and Terms of Service, revised from time to time, and you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CTSH is benefiting from expanding clientele and a strong partner base with a robust pipeline, which includes a favorable mix of business renewals and expansions of new opportunities.
The positive momentum is also reflected in its impressive third-quarter 2024 financial results. Cognizant reported revenues of $5 billion, representing a 3.5% sequential growth in constant currency and 2.7% year-over-year growth. This growth was driven by strong demand in specific sectors like health sciences and financial services.
In the third quarter of 2024, Health Science increased 7.6% year over year in constant currency, fueled by strong demand in the payer, provider, and life sciences sectors.
Cognizant Technology Solutions Corporation Price and Consensus
Financial Services returned to growth, with a slight 0.5% increase in constant currency and 0.7% year over year, driven by improving discretionary spending and strong demand.
Will CTSH’s Strong Partners Boost Prospects?
Cognizant’s expanding partner base, which includes NVIDIA (NVDA - Free Report) , Service Now (NOW - Free Report) and Palo Alto Networks (PANW - Free Report) has been noteworthy.
In the third quarter of 2024, CTSH signed six deals exceeding $100 million each, highlighting its ability to win large, strategic contracts. In total, 19 large deals have been signed in the year-to-date period, outpacing the 17 deals secured in 2023.
In the same quarter, CTSH announced a new collaboration with NVIDIA to enhance its data modernization offering. The collaboration will leverage the Cognizant Data and Intelligence Toolkit with the NVIDIA RAPIDS library to drive efficiency in cloud infrastructure operations and enable AI readiness.
Cognizant also expanded its partnership with ServiceNow as the first partner to bring the new Workflow Data Fabric to market, unifying business and technology data for AI agents with real-time, secure access.
Cognizant collaborated with Palo Alto Networks to deliver AI-driven cybersecurity solutions, enhancing security through platformization and reducing complexity for enterprises.
CTSH’s Strong Portfolio Boosts Prospect
Cognizant is heavily investing in AI, with a commitment of $1 billion to enhance platforms and capabilities. This investment reflects the company’s focus on leading in the rapidly evolving digital landscape.
In the third quarter of 2024, the company made significant progress in AI and automation, particularly through its Neuro IT Ops, Flowsource, and AI-driven platforms, which helped improve productivity and lower costs for clients, including in high-value areas like software development and IT operations.
Further expanding its portfolio, in October, Cognizant announced the launch of Cognizant Neuro Cybersecurity, a platform designed to enhance cybersecurity resilience by integrating and orchestrating various point solutions across the enterprise for improved decision-making and threat management. The launch underscores Cognizant’s commitment to bolstering its client’s digital security amid growing cyber threats.
Acquisitions have also played an important role in driving CTSH’s top-line growth. CTSH benefited from recent acquisitions, including Belcan, which contributed approximately 150 basis points to revenue growth in the third quarter of 2024.
Belcan’s integration enhanced CTSH’s presence in aerospace and defense and expanded its access to the ER&D services market, projected to outpace legacy IT services.
CTSH Initiates Strong 2024 Guidance
Cognizant expects fourth-quarter 2024 revenues between $5 billion and $5.1 billion, indicating growth of 5.1-7.1% (an increase of 4.8% to 6.8% on a cc basis).
The Zacks Consensus Estimate for fourth-quarter revenues is pegged at $5.07 billion, indicating year-over-year growth of 6.60%.
The consensus mark for earnings is pegged at $1.13 per share, which declined 4.2% over the past 30 days. The figure indicates a year-over-year decline of 4.24%.
For 2024, revenues are expected to be in the range of $19.7-$19.8 billion, indicating an increase of 1.6-2.1% on a reported basis (an increase of 1.4% to 1.9% on a cc basis). Acquisitions are expected to contribute 200 bps.
The Zacks Consensus Estimate for 2024 revenues is pegged at $19.72 billion, indicating year-over-year growth of 1.88%.
Adjusted earnings per share for 2024 are expected to be between $4.63 and $4.67.
The consensus mark for earnings is pegged at $4.66 per share, which increased 0.86% over the past 30 days. The figure implies a year-over-year increase of 2.42%.
Conclusion
Cognizant’s shares are cheap as suggested by a Value Score of B.
The forward 12-month Price/Sales ratio for CTSH stands at 2.03, lower than the industry’s 12.16.
Image: Bigstock
Cognizant Gains 6% in the Past Month: Should Investors Buy the Stock?
Cognizant Technology Solutions (CTSH - Free Report) shares have gained 6.1% in the past month compared with the Zacks Business - Software Services industry’s rise of 3.2% and the broader Zacks Computer & Technology sector’s return of 0.7%.
CTSH is benefiting from expanding clientele and a strong partner base with a robust pipeline, which includes a favorable mix of business renewals and expansions of new opportunities.
The positive momentum is also reflected in its impressive third-quarter 2024 financial results. Cognizant reported revenues of $5 billion, representing a 3.5% sequential growth in constant currency and 2.7% year-over-year growth. This growth was driven by strong demand in specific sectors like health sciences and financial services.
In the third quarter of 2024, Health Science increased 7.6% year over year in constant currency, fueled by strong demand in the payer, provider, and life sciences sectors.
Cognizant Technology Solutions Corporation Price and Consensus
Cognizant Technology Solutions Corporation price-consensus-chart | Cognizant Technology Solutions Corporation Quote
Financial Services returned to growth, with a slight 0.5% increase in constant currency and 0.7% year over year, driven by improving discretionary spending and strong demand.
Will CTSH’s Strong Partners Boost Prospects?
Cognizant’s expanding partner base, which includes NVIDIA (NVDA - Free Report) , Service Now (NOW - Free Report) and Palo Alto Networks (PANW - Free Report) has been noteworthy.
In the third quarter of 2024, CTSH signed six deals exceeding $100 million each, highlighting its ability to win large, strategic contracts. In total, 19 large deals have been signed in the year-to-date period, outpacing the 17 deals secured in 2023.
In the same quarter, CTSH announced a new collaboration with NVIDIA to enhance its data modernization offering. The collaboration will leverage the Cognizant Data and Intelligence Toolkit with the NVIDIA RAPIDS library to drive efficiency in cloud infrastructure operations and enable AI readiness.
Cognizant also expanded its partnership with ServiceNow as the first partner to bring the new Workflow Data Fabric to market, unifying business and technology data for AI agents with real-time, secure access.
Cognizant collaborated with Palo Alto Networks to deliver AI-driven cybersecurity solutions, enhancing security through platformization and reducing complexity for enterprises.
CTSH’s Strong Portfolio Boosts Prospect
Cognizant is heavily investing in AI, with a commitment of $1 billion to enhance platforms and capabilities. This investment reflects the company’s focus on leading in the rapidly evolving digital landscape.
In the third quarter of 2024, the company made significant progress in AI and automation, particularly through its Neuro IT Ops, Flowsource, and AI-driven platforms, which helped improve productivity and lower costs for clients, including in high-value areas like software development and IT operations.
Further expanding its portfolio, in October, Cognizant announced the launch of Cognizant Neuro Cybersecurity, a platform designed to enhance cybersecurity resilience by integrating and orchestrating various point solutions across the enterprise for improved decision-making and threat management. The launch underscores Cognizant’s commitment to bolstering its client’s digital security amid growing cyber threats.
Acquisitions have also played an important role in driving CTSH’s top-line growth. CTSH benefited from recent acquisitions, including Belcan, which contributed approximately 150 basis points to revenue growth in the third quarter of 2024.
Belcan’s integration enhanced CTSH’s presence in aerospace and defense and expanded its access to the ER&D services market, projected to outpace legacy IT services.
CTSH Initiates Strong 2024 Guidance
Cognizant expects fourth-quarter 2024 revenues between $5 billion and $5.1 billion, indicating growth of 5.1-7.1% (an increase of 4.8% to 6.8% on a cc basis).
The Zacks Consensus Estimate for fourth-quarter revenues is pegged at $5.07 billion, indicating year-over-year growth of 6.60%.
The consensus mark for earnings is pegged at $1.13 per share, which declined 4.2% over the past 30 days. The figure indicates a year-over-year decline of 4.24%.
For 2024, revenues are expected to be in the range of $19.7-$19.8 billion, indicating an increase of 1.6-2.1% on a reported basis (an increase of 1.4% to 1.9% on a cc basis). Acquisitions are expected to contribute 200 bps.
The Zacks Consensus Estimate for 2024 revenues is pegged at $19.72 billion, indicating year-over-year growth of 1.88%.
Adjusted earnings per share for 2024 are expected to be between $4.63 and $4.67.
The consensus mark for earnings is pegged at $4.66 per share, which increased 0.86% over the past 30 days. The figure implies a year-over-year increase of 2.42%.
Conclusion
Cognizant’s shares are cheap as suggested by a Value Score of B.
The forward 12-month Price/Sales ratio for CTSH stands at 2.03, lower than the industry’s 12.16.
Cognizant currently carries Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.